• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口咽癌放化疗所致口腔黏膜炎的镇痛阿片类药物需求的时间进程及预测因素

Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer.

作者信息

Alfieri Salvatore, Ripamonti Carla I, Marceglia Sara, Orlandi Ester, Iacovelli Nicola A, Granata Roberta, Cavallo Anna, Pozzi Paolo, Boffi Roberto, Bergamini Cristiana, Imbimbo Martina, Pala Laura, Resteghini Carlo, Mirabile Aurora, Locati Laura D, Licitra Lisa, Bossi Paolo

机构信息

Head and Neck Cancer Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Supportive Care Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

出版信息

Head Neck. 2016 Apr;38 Suppl 1:E1521-7. doi: 10.1002/hed.24272. Epub 2016 Feb 5.

DOI:10.1002/hed.24272
PMID:26849016
Abstract

BACKGROUND

Oral mucositis (OM)-related pain affects most patients with head and neck cancer during treatments, but its management is not standardized.

METHODS

We retrospectively collected data about the opioid therapy used for OM-induced pain in all patients with oropharyngeal cancer treated with chemoradiotherapy (CRT) between 2009 and 2013. To compare the different opioids, a conversion into oral morphine equivalent daily dose (OMEDD) was performed. The highest OMEDD (h-OMEDD) and the opioids' weekly increase were associated with patient, tumor, or treatment-related characteristics in order to identify predictive factors of opioid consumption.

RESULTS

Ninety-seven percent of patients received opioids. The h-OMEDD was significantly correlated with a higher OM-grade and a lower smoking history. The weekly opioids' increase was higher in patients with lower smoking history and human papillomavirus (HPV) positivity.

CONCLUSION

Opioid therapy remains the mainstay for OM-related pain management during CRT. The role of previous smoking and HPV on opioid use needs further confirmations. © 2016 Wiley Periodicals, Inc. Head Neck 38: E1521-E1527, 2016.

摘要

背景

口腔黏膜炎(OM)相关疼痛在头颈部癌患者的治疗过程中影响着大多数患者,但其管理并不规范。

方法

我们回顾性收集了2009年至2013年间所有接受放化疗(CRT)的口咽癌患者中用于OM引起疼痛的阿片类药物治疗的数据。为比较不同的阿片类药物,进行了换算成口服吗啡等效日剂量(OMEDD)的操作。将最高OMEDD(h - OMEDD)和阿片类药物的每周增加量与患者、肿瘤或治疗相关特征相关联,以确定阿片类药物消耗的预测因素。

结果

97%的患者接受了阿片类药物治疗。h - OMEDD与较高的OM分级和较低的吸烟史显著相关。吸烟史较低和人乳头瘤病毒(HPV)阳性的患者阿片类药物每周增加量更高。

结论

阿片类药物治疗仍然是CRT期间OM相关疼痛管理的主要手段。既往吸烟和HPV在阿片类药物使用方面的作用需要进一步证实。© 2016威利期刊公司。《头颈》38: E1521 - E1527, 2016。

相似文献

1
Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer.口咽癌放化疗所致口腔黏膜炎的镇痛阿片类药物需求的时间进程及预测因素
Head Neck. 2016 Apr;38 Suppl 1:E1521-7. doi: 10.1002/hed.24272. Epub 2016 Feb 5.
2
Professional oral health care reduces oral mucositis pain in patients treated by superselective intra-arterial chemotherapy concurrent with radiotherapy for oral cancer.专业口腔护理可减轻口腔癌患者在接受超选择性动脉内化疗联合放疗治疗时的口腔黏膜炎疼痛。
Support Care Cancer. 2015 Nov;23(11):3323-9. doi: 10.1007/s00520-015-2774-x. Epub 2015 May 20.
3
Use of a buprenorphine-based pain management protocol is associated with reduced opioid requirements and pain on swallowing in oral mucositis: a retrospective cohort study.基于丁丙诺啡的疼痛管理方案的使用与口腔黏膜炎中阿片类药物需求减少及吞咽疼痛减轻相关:一项回顾性队列研究。
Support Care Cancer. 2022 Jul;30(7):6013-6020. doi: 10.1007/s00520-022-07014-5. Epub 2022 Apr 11.
4
A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.一项关于 HMB/Arg/Gln 预防头颈部癌症患者放化疗后口腔黏膜炎的 II 期临床研究。
Support Care Cancer. 2018 Sep;26(9):3241-3248. doi: 10.1007/s00520-018-4175-4. Epub 2018 Apr 7.
5
[Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].[S-1同步放化疗后头颈部癌患者发生重度口腔黏膜炎的危险因素分析]
Yakugaku Zasshi. 2017;137(2):221-225. doi: 10.1248/yakushi.16-00077.
6
Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer.与头颈癌放化疗患者口腔黏膜炎评估相关的混杂因素。
Support Care Cancer. 2017 Sep;25(9):2743-2751. doi: 10.1007/s00520-017-3684-x. Epub 2017 Mar 28.
7
World Workshop on Oral Medicine VII: Non-opioid pain management of head and neck chemo/radiation-induced mucositis: A systematic review.第七届世界口腔医学研讨会:头颈部放化疗诱导黏膜炎的非阿片类药物疼痛管理:系统评价。
Oral Dis. 2019 Jun;25 Suppl 1:182-192. doi: 10.1111/odi.13074.
8
Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma.局部应用吗啡对头颈部癌同步放化疗后黏膜炎相关疼痛的影响。
Cancer. 2002 Nov 15;95(10):2230-6. doi: 10.1002/cncr.10938.
9
Low level helium neon laser therapy for chemoradiotherapy induced oral mucositis in oral cancer patients - a randomized controlled trial.低强度氦氖激光治疗口腔癌患者放化疗后口腔黏膜炎的随机对照试验。
Oral Oncol. 2012 Sep;48(9):893-7. doi: 10.1016/j.oraloncology.2012.03.008. Epub 2012 Apr 11.
10
Low level laser therapy for concurrent chemoradiotherapy induced oral mucositis in head and neck cancer patients - a triple blinded randomized controlled trial.低水平激光疗法治疗头颈部癌症患者同期放化疗引起的口腔黏膜炎——一项三盲随机对照试验。
Radiother Oncol. 2012 Sep;104(3):349-54. doi: 10.1016/j.radonc.2012.06.011. Epub 2012 Aug 10.

引用本文的文献

1
Predictive models for chemotherapy-induced oral mucositis: a systematic review.化疗引起的口腔黏膜炎的预测模型:一项系统综述
Front Oncol. 2025 Aug 20;15:1608505. doi: 10.3389/fonc.2025.1608505. eCollection 2025.
2
Pain Control in Oral Mucositis According to the Severity Scale: A Narrative Literature Review.根据严重程度量表进行口腔黏膜炎的疼痛控制:一项叙述性文献综述
J Clin Med. 2025 Jun 24;14(13):4478. doi: 10.3390/jcm14134478.
3
Phase IV study on the use of benzydamine mouthwash in radiation-induced oral mucositis in patients with head and neck cancer.
苄达明漱口水用于头颈部癌患者放射性口腔黏膜炎的IV期研究。
Front Oncol. 2024 Feb 26;14:1345129. doi: 10.3389/fonc.2024.1345129. eCollection 2024.
4
Association between trajectories of prescription opioid use and risk of opioid use disorder and overdose among US nonmetastatic breast cancer survivors.美国非转移性乳腺癌幸存者中处方类阿片使用轨迹与阿片类药物使用障碍和过量风险的关系。
Breast Cancer Res Treat. 2024 Apr;204(3):561-577. doi: 10.1007/s10549-023-07205-6. Epub 2024 Jan 8.
5
Wearing individualized 3D printed oral stent to protect normal tissues in patients with nasopharyngeal carcinoma during radiotherapy.佩戴个体化 3D 打印口腔支架保护鼻咽癌放疗患者正常组织。
J Appl Clin Med Phys. 2023 Dec;24(12):e14145. doi: 10.1002/acm2.14145. Epub 2023 Sep 7.
6
Methylene Blue for the Treatment of Radiation-Induced Oral Mucositis during Head and Neck Cancer Treatment: An Uncontrolled Cohort.亚甲蓝用于头颈部癌症治疗期间放射性口腔黏膜炎的治疗:一项非对照队列研究
Cancers (Basel). 2023 Aug 7;15(15):3994. doi: 10.3390/cancers15153994.
7
The changing face of head and neck cancer: are patients with human papillomavirus-positive disease at greater nutritional risk? A systematic review.头颈部癌症的变化面貌:人乳头瘤病毒阳性疾病患者的营养风险更高吗?一项系统评价。
Support Care Cancer. 2022 Sep;30(9):7191-7204. doi: 10.1007/s00520-022-07056-9. Epub 2022 Apr 27.
8
Diclofenac versus tramadol for mucositis related pain in head and neck cancer patients undergoing concurrent chemoradiation-a phase 3 study.双氯芬酸与曲马多治疗头颈部癌同步放化疗患者黏膜炎相关疼痛的3期研究
Ecancermedicalscience. 2021 Nov 18;15:1318. doi: 10.3332/ecancer.2021.1318. eCollection 2021.
9
Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients.鼻咽癌患者调强放疗和化疗期间放射性唾液腺功能障碍的建模
Cancers (Basel). 2021 Aug 6;13(16):3983. doi: 10.3390/cancers13163983.
10
Intravenous fluids for pain management in head and neck cancer patients undergoing chemoradiation.用于接受放化疗的头颈癌患者疼痛管理的静脉输液。
Ann Transl Med. 2021 May;9(10):912. doi: 10.21037/atm-20-3910.